| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 1996 Medical Council on Alcohol
research-article
AN OPEN MULTICENTRIC STUDY EVALUATING 4-HYDROXYBUTYRIC ACID SODIUM SALT IN THE MEDIUM-TERM TREATMENT OF 179 ALCOHOL DEPENDENT SUBJECTS
Internal Medicine 11 Chair, Catholic University ‘Sacro Cuore’ Rome, Italy
1Centre for the Study and Multidisciplinary Treatment for the Inadequate Use of Alcohol, University of Bologna Italy
2Various participating centres
*Author to whom correspondence should be addressed at: Istituto di Paiologia Medica I, Universita' degli Studi di Bologna, Bologna, Italy
Received 8 August 1995; first review notified 16 November 1995; accepted 10 December 1995
We report the results of an ‘open’ multicentre study evaluating the use, tolerability and therapeutic efficacy of the sodium salt of 4-hydroxybutyric acid (GHB) for the medium-term treatment of withdrawal symptoms in 179 patients with alcohol dependence followed up as outpatients. The follow-up of patients was 6 and 12 months after drug discontinuation. Following a daily oral administration of 50mg/kg for approximately 6 months, no serious systemic or single-organ consequences leading to drug discontinuation were reported, and tolerability was fair in all patients. Eleven subjects (10.1%) snowed craving for the drug and voluntarily increased their doses (6–7 times the recommended levels). GHB led to complete abstinence during drug administration in 78.0% of the patients. A significant reduction of compulsive desire (‘craving’) was observed in parallel, as deduced from evaluation of a specific questionnaire, the Alcohol Craving Scale. At follow-up examination, 43 of the treated subjects remained abstinent at 6 months, and 30 subjects were abstinent for 1 year after drug discontinuation.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  F. Caputo, S. Francini, M. Stoppo, F. Lorenzini, T. Vignoli, A. Del Re, C. Comaschi, L. Leggio, G. Addolorato, G. Zoli, et al. Incidence of craving for and abuse of gamma-hydroxybutyric acid (GHB) in different populations of treated alcoholics: an open comparative study J Psychopharmacol, November 1, 2009; 23(8): 883 - 890. [Abstract] [PDF]
|
|
|
|
 |
|
 E. Sanna, M. C. Mostallino, F. Busonero, G. Talani, S. Tranquilli, M. Mameli, S. Spiga, P. Follesa, and G. Biggio Changes in GABAA Receptor Gene Expression Associated with Selective Alterations in Receptor Function and Pharmacology after Ethanol Withdrawal J. Neurosci., December 17, 2003; 23(37): 11711 - 11724. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Lucht, K. U. Kuehn, J. Armbruster, G. Abraham, M. Gaensicke, S. Barnow, H. Tretzel, and H. J. Freyberger ALCOHOL WITHDRAWAL TREATMENT IN INTOXICATED VS NON-INTOXICATED PATIENTS: A CONTROLLED OPEN-LABEL STUDY WITH TIAPRIDE/CARBAMAZEPINE, CLOMETHIAZOLE AND DIAZEPAM Alcohol Alcohol., March 1, 2003; 38(2): 168 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Serra, G. Colombo, S. Melis, G. Vacca, M. A. M. Carai, and G. L. Gessa GAMMA-HYDROXYBUTYRIC ACID VERSUS ALCOHOL PREFERENCE IN SARDINIAN ALCOHOL-PREFERRING RATS Alcohol Alcohol., March 1, 2002; 37(2): 128 - 131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Nimmerrichter, H. Walter, K. E. Gutierrez-Lobos, and O. M. Lesch DOUBLE-BLIND CONTROLLED TRIAL OF {gamma}-HYDROXYBUTYRATE AND CLOMETHIAZOLE IN THE TREATMENT OF ALCOHOL WITHDRAWAL Alcohol Alcohol., January 1, 2002; 37(1): 67 - 73. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Garcia-Monco, M. G. Beldarrain, G. Addolorato, G. F. Stefanini, G. Gasbarrini, R. Saitz, P. G. O'Connor, and R. S. Schottenfeld Patients with Alcohol Problems N. Engl. J. Med., July 9, 1998; 339(2): 130 - 131. [Full Text]
|
|